The supplement aisle is a landscape of guesswork, where clinical evidence often loses out to marketing claims. For the health-conscious consumer, navigating it requires a leap of faith. PlanMySupps, a Paris-based startup founded in 2021, is a quiet bet that the leap should be replaced by a protocol. Its founders are not selling bottles. They are selling the infrastructure to build a personalized, evidence-based supplement plan, a software layer meant to sit between a user's health data and the crowded marketplace of pills and powders [PlanMySupps, retrieved 2024].
The evidence-based wedge
The company's core product is a protocol-generation engine. Users input their data, and the software outputs a structured supplement regimen. The critical differentiator, repeated throughout its materials, is the phrase "evidence-based." This is not an AI model trained on web forums. The company's intellectual wedge is nutritional epidemiology, the field that studies diet and health patterns in populations. Co-founder Jess Lytle holds an MSc in the discipline from Harvard, a credential prominently featured in her professional profile [LinkedIn, retrieved 2024]. The intent is to filter the universe of supplement claims through a clinical evidence sieve, offering a plan built on published research rather than influencer endorsements.
A founding team of science and coaching
The early-stage team is a classic two-founder blend of deep domain science and applied practice. Lytle provides the research rigor. Her co-founder and CEO, Cristina Gall, brings a background in personalized supplement coaching, also with ties to Harvard's public health school [RocketReach, retrieved 2024] [Cristina Gall - PlanMySupps | LinkedIn, retrieved 2026]. This pairing suggests a product philosophy: start with the clinical literature, then translate it into an actionable, coachable plan for an individual. Their public footprint is minimal, with no institutional funding or major media coverage yet on the record [Perplexity Sonar Pro Brief, retrieved 2024]. The company appears to be in a foundational, possibly bootstrapped, phase of proving its core thesis directly with consumers before scaling.
The crowded field of personalization
PlanMySupps enters a market where "personalization" is already a crowded label. It faces a range of competitors, from venture-backed DTC brands like Care/of and Rootine to more clinical-service oriented platforms. The table below outlines the competitive landscape the company is navigating.
| Company | Primary Model | Key Differentiator |
|---|---|---|
| PlanMySupps | Software protocol engine | Evidence-based, nutritional epidemiology focus |
| Rootine | DTC subscription | Micronutrient blood testing & customized beads |
| Care/of | DTC subscription | Lifestyle quiz & branded vitamin packs |
| Persona | DTC subscription | Registered dietitian-designed personalized packs |
| Hormonify | DTC & practitioner | Focus on hormonal health & practitioner network |
PlanMySupps's bet is that its emphasis on clinical evidence as a filter, rather than just lifestyle questions or single biomarker tests, creates a defensible position. Its product is the decision-making framework, theoretically agnostic to which supplement brands a user ultimately purchases. This asset-light, software-centric approach could allow it to scale recommendations without the capital-intensive burdens of inventory, manufacturing, or fulfillment.
The risks of an unregulated market
For all its scientific ambition, the company's path is lined with significant, industry-wide challenges. The dietary supplement market in the United States and many other regions is largely unregulated by bodies like the FDA for efficacy prior to sale. This creates a pervasive trust deficit that any new entrant must overcome.
- The validation gap. The company's website does not yet publish its specific algorithms, data partnerships, or details on its evidence-review process [Perplexity Sonar Pro Brief, retrieved 2024]. For a product selling scientific rigor, peer-reviewed validation or transparent methodology will be crucial for credibility, especially with a medically savvy audience.
- The consumer education hurdle. Convincing consumers to pay for a plan,rather than the supplements themselves,requires demonstrating tangible outcomes. Without the recurring revenue of a physical product subscription, the company must prove its software delivers value distinct from a free online article or a chat with a pharmacist.
- The scaling challenge. The direct-to-consumer health advice space is fiercely competitive for attention and marketing dollars. Moving upmarket to serve integrative medicine practitioners or clinics could offer a more viable enterprise path, but no B2B offering is visible on its public-facing pages today.
The company's success likely hinges on its ability to operationalize its founders' expertise into a scalable, trustworthy product. It must build a moat of proprietary clinical logic that competitors cannot easily replicate, and it must communicate that value in a market noisy with simpler, less rigorous claims.
For the patient or consumer navigating general wellness or subclinical deficiencies, the current standard of care is often a fragmented mix of internet research, anecdotal advice, and trial-and-error with over-the-counter products. A primary care physician may have limited time for detailed nutritional counseling, and even integrative practitioners can rely on experience as much as on evolving clinical literature. PlanMySupps is attempting to codify that literature into an accessible engine, betting that for a growing cohort of health-aware individuals, evidence is the most valuable supplement of all.
Sources
- [PlanMySupps, retrieved 2024] PlanMySupps, Personalized, Evidence-Based Supplement Plans | https://planmysupps.com/
- [LinkedIn, retrieved 2024] Jess (Jessica) Lytle's LinkedIn Profile | https://www.linkedin.com/in/jessicalytle/
- [RocketReach, retrieved 2024] Cristina Gall's RocketReach Profile | https://rocketreach.co/cristina-gall_b511394348572533
- [Cristina Gall - PlanMySupps | LinkedIn, retrieved 2026] Cristina Gall - PlanMySupps | LinkedIn | https://www.linkedin.com/in/cristinagall/